392: Infection and Rejection Risk Using Induction with Interleukin II Receptor Blockers vs. Antithymocyte Globulin vs. No Induction: A Multi-Institutional Study

S.V. Pamboukian; S.M. Pham; R.S.D. Higgins; B. Czerska; B.S. Clemson; J.K. Kirklin; R.N. Brown; C. White-Williams; Cardiac Transplant Research Database

doi:10.1016/j.healun.2007.11.403

Back

392: Infection and Rejection Risk Using Induction with Interleukin II Receptor Blockers vs. Antithymocyte Globulin vs. No Induction: A Multi-Institutional Study

Journal article

Peer reviewed

392: Infection and Rejection Risk Using Induction with Interleukin II Receptor Blockers vs. Antithymocyte Globulin vs. No Induction: A Multi-Institutional Study

S.V. Pamboukian, S.M. Pham, R.S.D. Higgins, B. Czerska, B.S. Clemson, J.K. Kirklin, R.N. Brown, C. White-Williams and Cardiac Transplant Research Database

The Journal of heart and lung transplantation, Vol.27(2), pp.S202-S202

2008

DOI: https://doi.org/10.1016/j.healun.2007.11.403

Metrics

3 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: 392: Infection and Rejection Risk Using Induction with Interleukin II Receptor Blockers vs. Antithymocyte Globulin vs. No Induction: A Multi-Institutional Study
Creators: S.V. Pamboukian - University of Alabama at Birmingham
S.M. Pham - University of Miami
R.S.D. Higgins - Rush University Medical Center
B. Czerska - Henry Ford Hospital
B.S. Clemson - Gift of Hope Organ and Tissue Donor Network
J.K. Kirklin - University of Alabama at Birmingham
R.N. Brown - University of Alabama at Birmingham
C. White-Williams - University of Alabama at Birmingham
Cardiac Transplant Research Database
Publication Details: The Journal of heart and lung transplantation, Vol.27(2), pp.S202-S202
Publisher: Elsevier Inc
Academic Unit: Benefits - Other; Human Resources
Language: English
Resource Type: Journal article
Record Identifier: 991031740217002976